{
    "clinical_study": {
        "@rank": "68731", 
        "arm_group": [
            {
                "arm_group_label": "0% arabinose meal sucrose/starch", 
                "arm_group_type": "Experimental", 
                "description": "A meal containing a bon with butter and marmalade, a cup cake, The and water"
            }, 
            {
                "arm_group_label": "5 % arabinose meal sucrose/starch", 
                "arm_group_type": "Other", 
                "description": "A meal containing a bon with butter and marmalade, a cup cake, The and water"
            }, 
            {
                "arm_group_label": "10 % arabinose meal sucrose/starch", 
                "arm_group_type": "Other", 
                "description": "A meal containing a bon with butter and marmalade, a cup cake, The and water"
            }, 
            {
                "arm_group_label": "0 % arabinose meal Starch", 
                "arm_group_type": "Other", 
                "description": "A meal containing two bons with butter and cheese, The and water"
            }, 
            {
                "arm_group_label": "5 % arabinose meal starch", 
                "arm_group_type": "Other", 
                "description": "A meal containing two bons with butter and cheese, The and water"
            }, 
            {
                "arm_group_label": "10 % arabinose meal starch", 
                "arm_group_type": "Other", 
                "description": "A meal containing two bons with butter and cheese, The and water"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the effect of a meal containing different doses\n      of L-arabinose, on the intestinal sucrase activity after intake We measure this by measuring\n      the glucose, insulin and c-peptide after meals. Other measurements are made (glucagon and\n      GLP-1) to explain the correlations."
        }, 
        "brief_title": "The Effects of L-arabinose in a Meal in Healthy Men", 
        "completion_date": {
            "#text": "March 2011", 
            "@type": "Actual"
        }, 
        "condition": "Glucose Metabolism", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy male\n\n          -  normal weight (BMI 18,5-25 kg/m2)\n\n          -  18-30 years of age\n\n        Exclusion Criteria:\n\n          -  Not healthy,including those with diabetes Mellitus, high bloodpressure, dyslipidemia\n             or a infectious diseases (hepatitis or HIV), gastrointestinal disorders\n\n          -  Central adipositas (defined as waist circumference > 94 cm for european men)\n\n          -  Daily intake of vitamins and minerals, 3 months before the trail starts and during\n             the trail.\n\n          -  elevated alcoholcunsumption(> 21 units af alcohol pr. week)\n\n          -  take medicine\n\n          -  Elite athlete with intensive training\n\n          -  given bloddonation within the last 3 months\n\n          -  smoking"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "17", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01801540", 
            "org_study_id": "H-2-2010-095"
        }, 
        "intervention": {
            "arm_group_label": [
                "0% arabinose meal sucrose/starch", 
                "5 % arabinose meal sucrose/starch", 
                "10 % arabinose meal sucrose/starch", 
                "0 % arabinose meal Starch", 
                "5 % arabinose meal starch", 
                "10 % arabinose meal starch"
            ], 
            "description": "L-arabinose is mixed into the dough of the buns and cup cakes", 
            "intervention_name": "L-arabinose - effect on glucose metabolism", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 27, 2013", 
        "number_of_arms": "6", 
        "official_title": "The Effects of L-arabinose in a Meal on Glucose Metabolism in Healthy Men", 
        "overall_official": {
            "affiliation": "Unit of Nutrition 5711, Rigshospitalet, Blegdamsvej 9, 2100 K\u00f8benhavn \u00d8", 
            "last_name": "Jens Rikardt Andersen, MD, lector", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Level of glucose over time, The AUC, the peak value and time to peak", 
                "measure": "Glucose", 
                "safety_issue": "No", 
                "time_frame": "-15, 0, 15, 30, 45, 60, 90, 120, 180 min"
            }, 
            {
                "description": "Level of insulin over time, the AUC, the peak value and time to peak", 
                "measure": "Insulin", 
                "safety_issue": "No", 
                "time_frame": "-15, 0, 15, 30, 45, 60, 90, 120, 180 min"
            }, 
            {
                "description": "Level of c-peptide over time, The AUC, the peak value and time to peak", 
                "measure": "C-peptide", 
                "safety_issue": "No", 
                "time_frame": "-15, 0, 15, 30, 45, 60, 90, 120, 180 min"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01801540"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Copenhagen", 
            "investigator_full_name": "AAstrup", 
            "investigator_title": "Dr.Med.Sci./Ph.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Level of glucagon over time, The AUC, the peak value and time to peak", 
                "measure": "Glucagon", 
                "safety_issue": "No", 
                "time_frame": "-15, 0, 15, 30, 45, 60, 90, 120, 180 min"
            }, 
            {
                "description": "Level of GLP-1 over time, The AUC, the peak value and time to peak", 
                "measure": "GLP-1", 
                "safety_issue": "No", 
                "time_frame": "-15, 0, 15, 30, 45, 60, 90, 120, 180 min"
            }
        ], 
        "source": "University of Copenhagen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Copenhagen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2010", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}